{"cell_type":{"bb55e4fd":"code","aa0fb92c":"code","533cd1a8":"code","ad36a419":"code","e6f9af2d":"code","a1db32b7":"code","0a75e57e":"code","36906383":"code","7d57f8dc":"code","1864c112":"code","5466375c":"code","9ae68dea":"code","0d07c8dc":"code","3293e1c0":"code","3fca7bbc":"code","074dcc16":"code","b67d7756":"code","4e6f2acd":"code","45989eba":"code","c50678f0":"code","a322dd33":"code","2499896e":"code","9ffffb60":"code","33cd56a4":"code","a1907d8a":"code","af73e848":"code","a4b159eb":"code","d010f818":"code","43f54df7":"code","d8245e85":"code","aac7027c":"code","4765b402":"code","69d60fea":"code","6465b7b5":"code","eccc5781":"code","3fb968c9":"code","97bb45ab":"code","c046a8e3":"code","e64efb5d":"code","f30622d6":"code","313c4eb8":"code","baf8611f":"code","f444b467":"code","6525c08b":"code","b52946a8":"code","9b43c752":"code","43c6df93":"code","64c6c320":"code","62fb3fca":"code","93837ef5":"code","5a73bdb7":"code","77dcfe5e":"code","17a569ae":"code","2ae7df55":"code","5d87b50e":"code","cde5e366":"code","c2fc7f32":"code","1f006292":"code","f0c9c526":"code","f2ba6894":"code","e31509a2":"code","e8a99827":"code","da1d4517":"code","e89796dd":"code","c98b9868":"code","63ceac03":"markdown","468b8661":"markdown","6c731eaf":"markdown","9a725a2b":"markdown","a440fc80":"markdown","0480c28b":"markdown","8d9b767c":"markdown","c555ae95":"markdown","9c472981":"markdown","13e861b0":"markdown","dcf95b46":"markdown","fcb15356":"markdown","f79f3361":"markdown","27e7ac3c":"markdown","c7aaf0f2":"markdown","0f8e9222":"markdown","a48c32dd":"markdown","b1429eb5":"markdown","f3d5830a":"markdown","39d1eae4":"markdown","9bf922b3":"markdown","b1b5a360":"markdown","63de9f94":"markdown","286a49b9":"markdown","c70d2369":"markdown","0cd9c4e9":"markdown","31a934e4":"markdown","f33a1213":"markdown","604e9bf0":"markdown","2f4ded6d":"markdown","96961535":"markdown","0a94a5d4":"markdown","33848c58":"markdown","63c122b9":"markdown","c83fe4f4":"markdown","4d8e59b0":"markdown","131690e6":"markdown","669a47ea":"markdown","a6cceec7":"markdown","3d298ffb":"markdown","783e0782":"markdown","1d368894":"markdown"},"source":{"bb55e4fd":"# This Python 3 environment comes with many helpful analytics libraries installed\n# It is defined by the kaggle\/python Docker image: https:\/\/github.com\/kaggle\/docker-python\n# For example, here's several helpful packages to load\n\nimport numpy as np # linear algebra\nimport pandas as pd # data processing, CSV file I\/O (e.g. pd.read_csv)\n\n# Input data files are available in the read-only \"..\/input\/\" directory\n# For example, running this (by clicking run or pressing Shift+Enter) will list all files under the input directory\n\nimport os\nfor dirname, _, filenames in os.walk('\/kaggle\/input'):\n    for filename in filenames:\n        print(os.path.join(dirname, filename))\n\n# You can write up to 20GB to the current directory (\/kaggle\/working\/) that gets preserved as output when you create a version using \"Save & Run All\" \n# You can also write temporary files to \/kaggle\/temp\/, but they won't be saved outside of the current session","aa0fb92c":"import pandas as pd\nimport matplotlib.pyplot as plt\nimport plotly.graph_objects as go\nimport plotly.express as px\nimport seaborn as sns\nimport warnings\nwarnings.filterwarnings(\"ignore\")","533cd1a8":"df1 = pd.read_csv('..\/input\/conditions-contributing-to-deaths-covid19\/owid-covid-data.csv')\ndf2 = pd.read_csv('..\/input\/conditions-contributing-to-deaths-covid19\/Provisional_COVID-19_Death_Counts_by_Sex__Age__and_State.csv')\ndf3 = pd.read_csv('..\/input\/conditions-contributing-to-deaths-covid19\/Deaths_involving_coronavirus_disease_2019__COVID-19__by_race_and_Hispanic_origin_group_and_age__by_state.csv')\ndf4 = pd.read_csv('..\/input\/conditions-contributing-to-deaths-covid19\/Conditions_contributing_to_deaths_involving_coronavirus_disease_2019__COVID-19___by_age_group_and_state__United_States.csv')","ad36a419":"df1.head(2)","e6f9af2d":"df2.head(10)","a1db32b7":"df1.columns","0a75e57e":"df1 = pd.DataFrame(df1, columns=['iso_code', 'continent', 'location', 'date', 'total_cases', 'new_cases','total_deaths', \n                                 'new_deaths','total_vaccinations', 'total_vaccinations_per_hundred', 'population',\n                                 'median_age', 'aged_65_older', 'aged_70_older','diabetes_prevalence', 'female_smokers', \n                                 'male_smokers'])","36906383":"df1.describe().T","7d57f8dc":"df1['date'] = pd.to_datetime(df1['date'])\ndf1 = df1.iloc[(df1['location']!='World').values]\ndf1.head(2)","1864c112":"fig = px.choropleth(df1, locations=\"location\", color=df1[\"total_cases\"],locationmode='country names', \n                    hover_name=\"location\",animation_frame=df1[\"date\"].dt.strftime('%Y-%m-%d'), # DataFrame\n                    title='New confirmed cases over time updated to 10 Apr 2021', color_continuous_scale=px.colors.sequential.matter)\nfig.update(layout_coloraxis_showscale=True)\nfig.show()","5466375c":"px.choropleth(df1.groupby(by='location').sum().reset_index(), locations=\"location\", locationmode='country names', \n              color='new_deaths',hover_name=\"location\", title='new_deaths due to Covid-19 updated on 10 Apr 2021', hover_data=['new_deaths'], \n              color_continuous_scale='matter')","9ae68dea":"col = 'new_cases'\ntemp = df1[df1[col]>0].sort_values(col, ascending=True)\nfig = px.scatter(temp, x='date', y='location', size=col, color=col, height=3500,color_continuous_scale='Viridis')\nfig.update_layout(yaxis = dict(dtick = 1))\nfig.update(layout_coloraxis_showscale=False)\nfig.show()","0d07c8dc":"temp = df1.groupby(by='location').sum().reset_index().sort_values('new_cases', ascending=False).iloc[:10, :]\nfig = px.scatter(temp, x='new_cases', y='new_deaths', color='location', size='new_cases', height=800, text='location', \n                 log_x=True, log_y=True,title='Deaths vs new cases of top 10 countries updated on 10 Apr 2021')\nfig.update_traces(textposition='top center')\nfig.update_layout(showlegend=False)\nfig.update_layout(xaxis_rangeslider_visible=True)\nfig.show()","3293e1c0":"temp = df1.groupby(by='location').sum().reset_index().sort_values('total_vaccinations', ascending=False).iloc[:20, :]\nfig = px.scatter(temp, x='new_cases', y='total_vaccinations', color='location', size='new_cases', height=800, text='location', \n                 log_x=True, log_y=True,title='total_vaccinations vs new cases updated on 10 Apr 2021')\nfig.update_traces(textposition='top center')\nfig.update_layout(showlegend=False)\nfig.update_layout(xaxis_rangeslider_visible=True)\nfig.show()","3fca7bbc":"temp = df1.groupby(by='location').sum().reset_index().sort_values('total_vaccinations', ascending=False).iloc[:20, :]\nfig = px.scatter(temp, x='new_cases', y='total_vaccinations', color='location', size='new_cases', height=800, text='location', \n                 log_x=True, log_y=True,title='total_vaccinations vs new cases updated on 10 Apr 2021')\nfig.update_traces(textposition='top center')\nfig.update_layout(showlegend=False)\nfig.update_layout(xaxis_rangeslider_visible=True)\nfig.show()","074dcc16":"df2.head(3)","b67d7756":"df2.columns","4e6f2acd":"#df2 = df2.drop(['Footnote'], axis=1)\noptions = ['0-17 years', '18-29 years', '30-39 years', '40-49 years', '50-64 years', '65-74 years', '75-84 years', '85 years and over']\ndf2 = df2.iloc[(df2['State']!='United States').values]\ndf2 = df2[df2['Age Group'].isin(options)]\ndf2.head(2)","45989eba":"conditions = [df2['State']=='Alabama', df2['State']=='Alaska', df2['State']=='Arizona', df2['State']=='Arkansas',\n              df2['State']=='California',df2['State']=='Colorado', df2['State']=='Connecticut', df2['State']=='Delaware',\n              df2['State']=='District of Columbia',df2['State']=='Florida', df2['State']=='Georgia',\n              df2['State']=='Hawaii', df2['State']=='Idaho', df2['State']=='Illinois', df2['State']=='Indiana',\n              df2['State']=='Iowa', df2['State']=='Kansas', df2['State']=='Kentucky', df2['State']=='Louisiana', \n              df2['State']=='Maine', df2['State']=='Maryland',df2['State']=='Massachusetts', df2['State']=='Michigan', \n              df2['State']=='Minnesota', df2['State']=='Mississippi', df2['State']=='Missouri', df2['State']=='Montana', \n              df2['State']=='Nebraska', df2['State']=='Nevada', df2['State']=='New Hampshire',df2['State']=='New Jersey', \n              df2['State']=='New Mexico', df2['State']=='New York', df2['State']=='New York City',df2['State']=='North Carolina',\n              df2['State']=='North Dakota', df2['State']=='Ohio', df2['State']=='Oklahoma', df2['State']=='Oregon',\n              df2['State']=='Pennsylvania', df2['State']=='Rhode Island', df2['State']=='South Carolina',\n              df2['State']=='South Dakota',df2['State']=='Tennessee', df2['State']=='Texas', df2['State']=='Utah', \n              df2['State']=='Vermont', df2['State']=='Virginia', df2['State']=='Washington', df2['State']=='West Virginia', \n              df2['State']=='Wisconsin', df2['State']=='Wyoming', df2['State']=='Puerto Rico']\n\nchoices = ['AL','AK','AZ','AR','CA','CO','CT','DE','DC','FL','GA','HI','ID','IL','IN','IA','KS','KY','LA','ME','MD',\n           'MA','MI','MN','MS','MO','MT','NE','NV','NH','NJ','NM','NY','NC','ND','OH','OK','OR','PA','PR','RI','SC',\n           'SD','TN','TX','UT','VT','VA','VI','WA','WV','WI','WY',]\ndf2['Code'] = np.select(conditions, choices, default='black')","c50678f0":"prop = 'COVID-19 Deaths'\nfig = px.choropleth(df2.groupby(by='Code').sum().reset_index(),  # Input Pandas DataFrame\n                    locations=\"Code\",  # DataFrame column with locations\n                    color=prop,  # DataFrame column with color values\n                    hover_name='Code', # DataFrame column hover info\n                    locationmode = 'USA-states') # Set to plot as US States\nfig.update_layout(title_text = prop, # Create a Title\n    geo_scope='usa'),  # Plot only the USA instead of globe\nfig.show()  # Output the plot to the screen","a322dd33":"x0 = 'Age Group'\nx1 = 'Total Deaths'\nx2 = 'COVID-19 Deaths'\nx3 = 'Pneumonia Deaths'\nx4 = 'Pneumonia and COVID-19 Deaths'\nx5 = 'Influenza Deaths'\nx6 = 'Pneumonia, Influenza, or COVID-19 Deaths'\ntemp = df2.groupby(by=x0).sum().reset_index()\nfig = go.Figure(data=[\n    go.Bar(name=x2, x=temp[x0], y=temp[x2]),\n    go.Bar(name=x3, x=temp[x0], y=temp[x3]),\n    go.Bar(name=x4, x=temp[x0], y=temp[x4]),\n    go.Bar(name=x5, x=temp[x0], y=temp[x5]),\n    go.Bar(name=x6, x=temp[x0], y=temp[x6])])\nfig.update_layout(barmode='group')\nfig.update_layout(legend=dict(orientation=\"h\",\n    yanchor=\"bottom\",y=1.02,xanchor=\"right\",x=1))\nfig.show()","2499896e":"px.bar(df2.groupby(by='Age Group').sum().reset_index(),x='Age Group', y='Pneumonia and COVID-19 Deaths')","9ffffb60":"import plotly.graph_objects as go\ntemp = df2.groupby(by='Age Group').sum().reset_index()\nfig = go.Figure(data=go.Scatterpolar(r=[temp['Pneumonia and COVID-19 Deaths'][2],temp['Pneumonia and COVID-19 Deaths'][3],temp['Pneumonia and COVID-19 Deaths'][4],temp['Pneumonia and COVID-19 Deaths'][5],temp['Pneumonia and COVID-19 Deaths'][6]],\n  theta=['30-49 years', '50-64 years','65-74 years', '75-84 years', '85 years and over'],\n  fill='toself'))\nfig.update_layout(polar=dict(radialaxis=dict(visible=True),),showlegend=False,title=\"Pneumonia and COVID-19 Deaths\")\nfig.show()","33cd56a4":"fig = go.Figure(data=[go.Pie(labels=df2['Age Group'], values=df2['Total Deaths'], hole=.3)])\nfig.update_layout(legend=dict(orientation=\"h\",\n    yanchor=\"bottom\",y=1.02,xanchor=\"right\",x=1))\nfig.show()","a1907d8a":"plt.figure(figsize=(15,10))\nxprop = 'Age Group'\nyprop = 'COVID-19 Deaths'\nsns.boxplot(data=df2, x=xprop, y=yprop, hue='Sex')\nplt.xlabel('{} range'.format(xprop), size=14)\nplt.ylabel('Number of {}'.format(yprop), size=14)\nplt.title('Boxplot of {}'.format(yprop), size=20)\nplt.show()","af73e848":"px.violin(df2, y='Pneumonia, Influenza, or COVID-19 Deaths', x='Age Group', color=None, \n          box=True, points=\"all\", hover_data=df2.columns)","a4b159eb":"yprop = 'Pneumonia and COVID-19 Deaths'\nxprop = 'Pneumonia Deaths'\nh= 'Age Group'\npx.scatter(df2, x=xprop, y=yprop, color=h, marginal_y=\"violin\", marginal_x=\"box\", trendline=\"ols\", template=\"simple_white\")","d010f818":"yprop = 'Pneumonia, Influenza, or COVID-19 Deaths'\nxprop = 'Influenza Deaths'\nh= 'Age Group'\npx.scatter(df2, x=xprop, y=yprop, color=h, marginal_y=\"violin\", marginal_x=\"box\", trendline=\"ols\", template=\"simple_white\")","43f54df7":"x0 = 'Age Group'\nx1 = 'Pneumonia Deaths'\nx2 = 'Pneumonia and COVID-19 Deaths'\n\ntemp = df2.groupby(by=x0).sum().reset_index()\nx = temp[x1]\ny = temp[x2]\nfig, ax = plt.subplots(figsize=(15,15))\nfor xi,yi in zip(x,y):\n    r2i = xi \/ (xi + yi)\n    r1i = 1 - r2i\n    print(r1i)\n    ax.pie([r1i,r2i], colors=['indigo', \"gold\"],\n           center=(xi, yi), radius=xi\/20, \n           wedgeprops=dict(width=(xi\/20)\/2), frame=True)\nax.autoscale()\nplt.show()","d8245e85":"df3.head(2)","aac7027c":"df3['Age group'].unique()","4765b402":"options = ['0-17 years','18-29 years','30-49 years', '50-64 years', '65-74 years', '75-84 years', '85 years and over']\ndf3 = df3.iloc[(df3['State']!='United States').values]\ndf3 = df3[df3['Age group'].isin(options)]\ndf3.head(2)","69d60fea":"x0 = 'Race and Hispanic Origin Group'\nx1 = 'Total Deaths'\nx2 = 'COVID-19 Deaths'\nx3 = 'Pneumonia Deaths'\nx4 = 'Pneumonia and COVID-19 Deaths'\nx5 = 'Influenza Deaths'\nx6 = 'Pneumonia, Influenza, or COVID-19 Deaths'\npx.scatter(df3.groupby(by=x0).sum().reset_index(), x=x0, y=x1, color=x4, size=x3)","6465b7b5":"fig = go.Figure(data=[go.Pie(labels=df3['Race and Hispanic Origin Group'], values=df3['Total Deaths'], hole=.3)])\nfig.update_layout(legend=dict(orientation=\"h\",yanchor=\"bottom\",y=1.02,xanchor=\"right\",x=1))\nfig.show()","eccc5781":"px.bar(df3, x='Race and Hispanic Origin Group', y='Pneumonia and COVID-19 Deaths', \n       color='Age group', title='Pneumonia and COVID-19 Deaths')","3fb968c9":"fig = px.box(df3, x='Age group',y='Pneumonia, Influenza, or COVID-19 Deaths', color='Race and Hispanic Origin Group', notched=True)\nfig.update_layout(legend=dict(orientation=\"h\",yanchor=\"bottom\",y=1.02,xanchor=\"right\",x=1))\nfig.show()","97bb45ab":"plt.figure(figsize=(15,10))\nxprop = 'Age group'\nyprop = 'COVID-19 Deaths'\nsns.boxplot(data=df3, x=xprop, y=yprop, hue='Race and Hispanic Origin Group')\nplt.xlabel('{} range'.format(xprop), size=14)\nplt.ylabel('Number of {}'.format(yprop), size=14)\nplt.title('Boxplot of {}'.format(yprop), size=20)\nplt.show()","c046a8e3":"yprop = 'Pneumonia and COVID-19 Deaths'\nxprop = 'Pneumonia Deaths'\nh= 'Race and Hispanic Origin Group'\nfig = px.scatter(df3, x=xprop, y=yprop, color=h, marginal_y=\"violin\", marginal_x=\"box\", trendline=\"ols\", template=\"simple_white\")\nfig.update_layout(legend=dict(orientation=\"h\",yanchor=\"bottom\",y=1.02,xanchor=\"right\",x=1))\nfig.show()","e64efb5d":"yprop = 'Influenza Deaths'\nxprop = 'Pneumonia, Influenza, or COVID-19 Deaths'\nh= 'Race and Hispanic Origin Group'\nfig=px.scatter(df3, x=xprop, y=yprop, color=h, marginal_y=\"violin\", marginal_x=\"box\", trendline=\"ols\", template=\"simple_white\")\nfig.update_layout(legend=dict(orientation=\"h\",yanchor=\"bottom\",y=1.02,xanchor=\"right\",x=1))\nfig.show()","f30622d6":"df4 = df4.iloc[(df4['State']!='US').values]\ndf4.head(2)","313c4eb8":"df4['Condition Group'].unique()","baf8611f":"df4['Condition'].unique()","f444b467":"x0 = 'Age Group'\nx1 = 'Condition Group'\nx3 = 'COVID-19 Deaths'\nx4 = 'Number of Mentions'\n\npx.scatter(df4.groupby(by=x1).sum().reset_index(), x=x1, y=x3, color=x4, size=x3)","6525c08b":"import plotly.graph_objects as go\ntemp = df4.groupby(by='Condition Group').sum().sort_values(by='COVID-19 Deaths', ascending=False).reset_index()\n\nfig = go.Figure(data=go.Scatterpolar(r=[temp['COVID-19 Deaths'][0],temp['COVID-19 Deaths'][1],temp['COVID-19 Deaths'][2],temp['COVID-19 Deaths'][4],temp['COVID-19 Deaths'][5]],\n  theta=['Respiratory diseases','COVID-19','Circulatory diseases','Diabetes','Vascular and unspecified dementia'],\n  fill='toself'))\nfig.update_layout(polar=dict(radialaxis=dict(visible=True),),showlegend=False,title=\"COVID-19 Deaths by Group condition\")\nfig.show()","b52946a8":"fig = go.Figure(data=[go.Pie(labels=df4['Condition Group'], values=df4['COVID-19 Deaths'], hole=.3)])\nfig.update_layout(legend=dict(orientation=\"h\",yanchor=\"bottom\",y=1.02,xanchor=\"right\",x=1))\nfig.show()","9b43c752":"df4['Age Group'].unique()","43c6df93":"option = ['0-24', '25-34', '35-44', '45-54', '55-64', '65-74', '75-84','85+']\ndf4 = df4[df4['Age Group'].isin(option)]\ndf4 = df4[df4['State']!='US']","64c6c320":"fig = px.scatter(df4.groupby(by=['Condition Group','Condition', 'Age Group']).sum().reset_index(), \n           x='Condition Group', y='Age Group', color='COVID-19 Deaths', size='COVID-19 Deaths')\nfig.update_yaxes(automargin=True)","62fb3fca":"fig = px.box(df4, x='Condition Group',y='COVID-19 Deaths', color='Age Group', notched=True)\nfig.update_layout(legend=dict(orientation=\"h\",yanchor=\"bottom\",y=1.02,xanchor=\"right\",x=1))\nfig.show()","93837ef5":"fig = go.Figure(data=[go.Pie(labels=df4['Condition'], values=df4['COVID-19 Deaths'], hole=.3)])\nfig.update_layout(legend=dict(orientation=\"h\",yanchor=\"bottom\",y=1.02,xanchor=\"right\",x=1))\nfig.show()","5a73bdb7":"resp = df4[(df4['Condition Group']=='Respiratory diseases').values]\ncov = df4[(df4['Condition Group']=='COVID-19').values]\ncir = df4[(df4['Condition Group']=='Circulatory diseases').values]\ndiab = df4[(df4['Condition Group']=='Diabetes').values]\nother = df4[(df4['Condition Group']=='All other conditions and causes (residual)').values]","77dcfe5e":"px.treemap(resp.groupby(by='Condition').sum().reset_index(), path=['Condition'], labels='Condition', \n           values='COVID-19 Deaths', title='COVID-19 Deaths by Respiratory diseases')","17a569ae":"fig = go.Figure(data=[go.Pie(labels=resp['Condition'], values=resp['COVID-19 Deaths'], hole=.3)])\nfig.update_layout(legend=dict(orientation=\"h\",yanchor=\"bottom\",y=1.02,xanchor=\"right\",x=1))\nfig.show()","2ae7df55":"px.box(cov, x='Age Group', y=\"COVID-19 Deaths\", title='Deaths due to Covid, directly')","5d87b50e":"fig = go.Figure(data=[go.Pie(labels=cir['Condition'], values=cir['COVID-19 Deaths'], pull=[0, 0, 0, 0, 0, 0.30, 0])])\nfig.update_layout(legend=dict(orientation=\"h\",yanchor=\"bottom\",y=1.02,xanchor=\"right\",x=1))\nfig.show()","cde5e366":"px.bar(diab, x='Age Group', y='COVID-19 Deaths')","c2fc7f32":"df4['COVID-19 Deaths'].fillna(value=0,inplace=True)","1f006292":"df4.isnull().sum()","f0c9c526":"from scipy.stats import ttest_ind\n\ndef Series_stats(df_in, var, category, prop1, prop2):\n    df = df_in\n\n    # Step 1: State the null and alternative hypothesis and select a level of significance is 5% or 0.05\n\n    # Step 2: Collect data and calculate the values of test statistic\n    s1 = df[(df[category]==prop1)][var]\n    s2 = df[(df[category]==prop2)][var]\n    t, p = ttest_ind(s1,s2,equal_var = False)\n    print(\"Two-sample t-test: t={}, p={}\".format(round(t,5),p))\n\n    # Step 3: Compare the probability associated with the test statistic with level of significance specified\n    if ((p < 0.05) and (np.abs(t) > 1.96)):\n        print(\"\\n REJECT the Null Hypothesis and state that: \\n at 5% significance level, the mean {} of {}-{} and {}-{} are not equal.\".format(var, prop1, category, prop2, category))\n        print(\"\\n YES, the {} of {}-{} differ significantly from {}-{} in the current dataset.\".format(var, prop1, category, prop2, category))\n        print(\"\\n The mean value of {} for {}-{} is {} and for {}-{} is {}\".format(var, prop1, category, round(s1.mean(),2), prop2, category, round(s2.mean(),2)))\n    else:\n        print(\"\\n FAIL to Reject the Null Hypothesis and state that: \\n at 5% significance level, the mean {} of {} - {} and {} - {} are equal.\".format(var, prop1, category, prop2, category))\n        print(\"\\n NO, the {} of {}-{} NOT differ significantly from {}-{} in the current dataset\".format(var, prop1, category, prop2, category))\n        print(\"\\n The mean value of {} for {}-{} is {} and for {}-{} is {}\".format(var, prop1, category, round(s1.mean(),2), prop2, category, round(s2.mean(),2)))","f2ba6894":"Series_stats(df4, 'COVID-19 Deaths','Age Group','25-34','55-64')","e31509a2":"Series_stats(df4, 'COVID-19 Deaths','Condition Group','Respiratory diseases','Circulatory diseases')","e8a99827":"Series_stats(df4, 'COVID-19 Deaths','Condition Group','Diabetes','Obesity')","da1d4517":"Series_stats(df4, 'COVID-19 Deaths','Condition','COVID-19','Diabetes')","e89796dd":"Series_stats(df4, 'COVID-19 Deaths','Condition','COVID-19','Hypertensive diseases')","c98b9868":"Series_stats(df4, 'COVID-19 Deaths','Condition','Diabetes','Hypertensive diseases')","63ceac03":"<h3> 2. Race and Hispanic origin and Covid-19 <h3>","468b8661":"<h2> II. Covid-19 new cases and deaths number world wide <h2>","6c731eaf":"There are multiple reasons for these disparities, but they may be based in differences in underlying medical conditions among the races, according to Lisa Cooper, M.D., director of the Johns Hopkins Center for Health Equity.\n\nLiving conditions, socioeconomic status and access to healthcare (and insurance) also play a role in exposure, transmission and ability to seek medical help.","9a725a2b":"Although the number of covid-19 infections is lower, there are more deaths from covid in Brazil than in India.","a440fc80":"But, remember that, COVID-19 is [not \u2018just another flu\u2019 ](https:\/\/www.reuters.com\/article\/uk-factcheck-not-all-covid19-victims-had\/fact-check-not-all-covid-19-victims-had-underlying-health-conditions-new-coronavirus-is-not-just-another-flu-idUSKBN28A2QE)","0480c28b":"<h2> I. Introduction : <\/h2> ","8d9b767c":"Early on in the coronavirus disease (COVID-19) pandemic, there was little data on the virus and how it affects the body. As the virus spread across the globe, data showed that some people were at a higher risk of developing severe disease and dying from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.\n\nThe high-risk individuals are those who are older than 65 years old, those who have weakened immune systems, and those with underlying health conditions, such as heart disease, hypertension, diabetes, obesity, kidney disease, and lung disease, among others.\n\nNow, the U.S. Centers for Disease Control and Prevention (CDC) reports that a majority of deaths in the United States tied to COVID-19 had contributing conditions or comorbidities. Let's start to analyse the data.","c555ae95":"The top underlying health conditions include influenza and pneumonia, respiratory failure, hypertensive disease, diabetes, cardiac arrest, vascular and unspecified dementia, renal failure, heart failure and other medical conditions.\n\nThe leading co-morbidities is shown and we could see that the Covid-19 deaths contribution is increasing and it's TRUE that Covid-19 IS NOT JUST a NEW FLU.","9c472981":"Data used in this Notebook are taken from [CDC](https:\/\/ourworldindata.org\/coronavirus-source-data).\n\nWhen the Food and Drug Administration (FDA) authorizes or approves a COVID-19 vaccine, the Advisory Committee on Immunization Practices (ACIP) quickly hold a public meeting to review all available data about that vaccine. From these data, ACIP will then vote on whether to recommend the vaccine and, if so, who should receive it.\n\nOn December 1, 2020, ACIP recommended that health care personnel and residents of long-term care facilities be offered COVID-19 vaccine in the initial phase of the vaccination program.\n\nOn December 11, 2020, the FDA issued an Emergency Use Authorization for use of the Pfizer-BioNTech COVID-19 vaccineexternal icon in persons aged 16 years and older for the prevention of COVID-19.\n\nOn December 13, 2020, the ACIP issued recommendations for the use of Pfizer-BioNTech\u2019s COVID-19 vaccine for the prevention of COVID-19.\n\nOn December 18, 2020, the FDA issued an Emergency Use Authorization for the use of the Moderna COVID-19 vaccineexternal icon for use in individuals 18 years of age and older.\n\nOn December 20, 2020, ACIP issued recommendations for the use of Moderna COVID-19 vaccine for the prevention of COVID-19.\n\nOn December 20, 2020, ACIP updated interim vaccine allocation recommendations.","13e861b0":"So, stopping a pandemic requires using all the tools available. \n\nVaccines work with your immune system so your body will be ready to fight the virus if you are exposed. Other steps, like covering your mouth and nose with a mask and staying at least 6 feet away from others, help reduce your chance of being exposed to the virus or spreading it to others. \n\nGoals for vaccination if supply is limited:\n\n+ Decrease death and serious disease as much as possible\n\n+ Preserve functioning of society\n\n+ Reduce the extra burden the disease is having on people already facing disparities","dcf95b46":"Before going to study the effect of the underlying condition of Covid-19 patients to the death rate, we resume the Covid cases and deaths number worldwide.","fcb15356":"<h1 align=\"center\"> Covid-19: Who should get vaccine first? <\/h1>\n<img align = \"center\" <img src=\"https:\/\/i.ibb.co\/L6zMgcd\/vac.jpg\" alt=\"vac\" border=\"0\"><\/a>","f79f3361":"The US, Brazil and India are the three most severely affected countries in the world.","27e7ac3c":"<h2> V. 4. Statistics <h2>","c7aaf0f2":"Groups considered for early vaccination if supply is limited? While we wait for the vaccine to be enough for everyone, we analyze who should be the first to be vaccinated? \nWe are waiting for an official recommendation, four groups to possibly recommend for early COVID-19 vaccination if supply is limited:\n\n+ Healthcare personnel\n\n+ Workers in essential and critical industries\n\n+ People at high risk for severe COVID-19 illness due to underlying medical conditions\n\n+ People 65 years and older\n\nWhat else?","0f8e9222":"Deaths due to pneumonia and \/ or Covid-19 mainly occur in patients over 50 years of age, most serious is for patients over 75 years old. So, NOT just over 65 years old as announced previously by CDC.","a48c32dd":"Deaths involving coronavirus disease 2019 (COVID-19), pneumonia, and influenza reported to NCHS by sex and age group. United States. Week ending 2\/1\/2020 to 1\/12\/2021.\n\nThus, New York is the origin of the epidemic, but TX, NC, CA, FL are the states with the highest number of deaths in the United States.","b1429eb5":"The disparity in mortality rates for Hispanics is greatest among those 30 to 49, followed by 50 to 64. For White, mortality disparity is greatest for those over 65.","f3d5830a":"Among total number of people who were death and for whom the CDC has race and ethnicity information:\n\n+ 9.84 percent of patients are Hispanic, they make up 18 percent of the U.S. population;\n+ 13 percent are black, while they constitute 13 percent of the population; \n+ and 0.675 percent are Native American or Alaskan Natives, nearly double their representation in the overall population.","39d1eae4":"<h2> IV. Who should take vaccine first? <h2>","9bf922b3":"What are comorbidities?\n\nThe CDC reports that comorbidity is more than one disease or condition that is present in the same person at the same time. These conditions are often chronic or long-term diseases, which are also called comorbid conditions, multimorbidity, multiple chronic conditions, or coexisting conditions.\n\nAmid the coronavirus pandemic, the CDC said that recent data has shown that the increased risk of COVID-19 severe disease or even death in people with other conditions. Further, people of any age with underlying medical conditions are at a heightened risk for severe illness from the coronavirus infection. The conditions include cancer, chronic kidney disease, chronic obstructive pulmonary disease, immunocompromised people, those who underwent organ transplant, obesity, sickle cell disease, severe heart conditions, and type 2 diabetes.\n\nSome individuals may be at an increased risk from COVID-19 infection if they have asthma, cerebrovascular disease, cystic fibrosis, high blood pressure, HIV, immune deficiencies, dementia, liver disease, smoking, pregnancy, pulmonary fibrosis, thalassemia, and type 1 diabetes.\n\nGlobally, the number of recorded infections has surpassed 136,475,875 with over 2,945,824 lives lost (updated on 10 Apr 2021).\n\nLet's discover.","b1b5a360":"We remove the 'Footnote' column and select only \"Age group\" ranges for this study, as following: ","63de9f94":"+ And this analyse also shows that non-Hispanic white populations account for the majority of deaths related to COVID-19 \u201373 percent, but account for 60% of the U.S. population. \n+ This means, Hispanics and Blacks have a disproportionally high percentage of deaths from COVID-19. The mortality rate for Asians, in contrast, is less than their percentage of the population.","286a49b9":"In all ages, Men have a higher mortality than Women, except for those over 85, the majority is Female. The are lot of outliers on age 50+, this could be due to some other serious disease or specific reasons NOT just due to the combination of Covid-19 and  Pneumonia \/ Influenza.","c70d2369":"<h2> VI. Recommendations and conclusions <h2>","0cd9c4e9":"And then the data.","31a934e4":"Based on the above analysis and following the tendency of the data during last 2 weeks, we have some conclusion & recommendation as following:\n\nConclusions:\n+ The most 3 countries effected: US, Brazil, India.\n+ Top 3 countries with the most vaccines: \u00da, China, Israel\n\nRecommendations:\n\n+ US States should have vaccines first: TX, CA, NC, FL\n\nPeople should have vaccine firest:\n+ Aged over 65+\n+ Male aged 65+ and Female aged 85+\n+ Individuals with any underlying medical condition: Pneumonia, Influenza\n+ Black-race group with Pneumina comorbidities first, then Asian with Pneumina then White-groupe with Pneumina\n+ People have underlying issues related to: Respiratory > Circulatory > Diabeties or Hypertensive > Cardiac arrest > Ischemic heart disease.\n+ But, for Race group: Non-Hispanic-White > Black > Hispanic, in priority.\n","f33a1213":"The number of new covid-19 infections globally is still increasing day by day, and global deaths have not stopped. As of December 26, 2020, the number of infections worldwide was 80,640,724 with 1,763,912 deaths.","604e9bf0":"For deaths with conditions or causes in addition to COVID-19, on average, there were around 2 additional conditions or causes per death. Note that, the number of mentions for each condition or cause is shown for all deaths.","2f4ded6d":"<h2> LIST OF TOPICS IN THIS STUDY <h2>\n\n[Data taken from CDC](https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/covid_weekly\/index.htm)\n    \n+ Age and sex \n+ Race and Hispanic origin\n+ Comorbidities","96961535":"Function to check statistical hypothesis test","0a94a5d4":"## ","33848c58":"Of course, people with certain underlying medical conditions are at increased risk for severe COVID-19 illness, regardless of their age. Severe illness means that the person with COVID-19 may require hospitalization, intensive care, or a ventilator to help them breathe, or that they may even die. Early vaccine access is critical to ensuring the health and safety of this population that is disproportionately affected by COVID-19.\n\nAmong adults, the risk for severe illness and death from COVID-19 increases with age, with older adults at highest risk. Early vaccine access is critical to help protect this population that is disproportionately affected by COVID-19.","63c122b9":"<h2> III. COVID-19 vaccine <h2>","c83fe4f4":"<h3> 3. Comorbidities and Covid-19 <h3>","4d8e59b0":"Fortunately, by December 2020, the world found a new light at the end of the tunnel of Covid-19 when there were two companies producing vaccines and a number of other companies doing commercial trials. Although the number of vaccines is limited compared to expectations, [the World is still hoping to have enough vaccines for everyone soon by 2021](https:\/\/www.raps.org\/news-and-articles\/news-articles\/2020\/3\/covid-19-vaccine-tracker).","131690e6":"<h3> 1. Underlying health condition (Pneumonia, Influenza) and Covid-19 <h3>","669a47ea":"As such, patients dying from Covid may be of any age, not necessarily older than 65 years. This shows the dangers of Covid-19, which is not a common new flu. Therefore, there should be vaccines for all ages soon, which is what we want in the future.","a6cceec7":"In this section, the coronavirus disease 2019 (COVID-19) deaths are based on a current flow of mortality data in the United States updated on 15 Feb, 2021 (Counts include deaths occurring within the 50 states and the District of Columbia).\n\nWe next study the indicators that can be used to illustrate potential differences in the burden of deaths due to COVID-19 reported for each race and Hispanic origin group.","3d298ffb":"Let's start by importing the librairies that will be used in this Notebook.","783e0782":"When a new flu strain is identified, like H1N1 in 2009, vaccine manufacturers can use the same processes that are used to make the annual seasonal flu vaccine, saving valuable time. Unlike flu, coronaviruses do not yet have licensed vaccines or processes to build on. In addition, the coronavirus that causes COVID-19 is a new virus, so entirely new vaccines must be developed and tested to ensure they work and are safe. There are many steps in the vaccine testing and approval process. Multiple agencies and groups in the United Statesexternal iconexternal icon are working together to make sure that a safe and effective COVID-19 vaccine is available as quickly as possible.\n\nMultiple COVID-19 vaccines are under development. Large-scale (Phase 3) clinical trials are in progress or being planned for five COVID-19 vaccines in the United States.\n\nAt first, there will be a limited supply of COVID-19 vaccine. Operation Warp Speed is working to get those first vaccine doses out once a vaccine is authorized or approved and recommended, rather than waiting until there is enough vaccine for everyone. However, it is important that the initial supplies of vaccine are given to people in a fair, ethical, and transparent way.\n\nSince the pandemic began, ACIP has been holding special meetings to review U.S. data on COVID-19 and the vaccines in development to help prevent it. Before making recommendations, ACIP plans to review all available clinical trial information, including descriptions of:\n\n+ Who is receiving each candidate vaccine (age, race, ethnicity, underlying medical conditions)\n+ How different groups respond to the vaccine\n+ Side effects experienced?","1d368894":"These illustrations shown that Americans who have died from COVID-19 also had other contributing conditions. The number of deaths with each condition or cause is shown for all deaths.\n\nThis study shown that, 27.5% of deaths listed COVID-19 as the only cause (compared to only 6 percent published previously on April 2020), revealing that 72.5 percent of the patients who have died from the infection also had other underlying health conditions."}}